These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 33389509

  • 21. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA, Tagle R, Jara A.
    Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ.
    Front Immunol; 2018 Jun; 9():612. PubMed ID: 29670616
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Perkins SJ.
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):120-127.e4. PubMed ID: 32553244
    [Abstract] [Full Text] [Related]

  • 28. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y, Matsumoto M.
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report.
    Osawa K, Yamamoto S, Yamano Y, Kita A, Okamoto K, Kato N, Tatematsu Y, Kojima F, Ohya M, Hara S, Murata SI, Inoue N, Maruyama S, Araki SI.
    Intern Med; 2024 Jun 15; 63(12):1777-1782. PubMed ID: 37926536
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options.
    Sanghera P, Ghanta M, Ozay F, Ariyamuthu VK, Tanriover B.
    Am J Med Sci; 2017 Dec 15; 354(6):533-538. PubMed ID: 29208248
    [Abstract] [Full Text] [Related]

  • 37. Atypical hemolytic uremic syndrome with C3 mutation: A case report and literature review.
    Liu J, Xiao J, Chen L, Peng Y.
    Clin Nephrol; 2021 Mar 15; 95(3):156-160. PubMed ID: 33210998
    [Abstract] [Full Text] [Related]

  • 38. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM.
    Med Clin (Barc); 2015 Nov 20; 145(10):438-45. PubMed ID: 25433773
    [Abstract] [Full Text] [Related]

  • 39. Eculizumab in the treatment of membranoproliferative glomerulonephritis.
    Bomback AS.
    Nephron Clin Pract; 2014 Nov 20; 128(3-4):270-6. PubMed ID: 25402185
    [Abstract] [Full Text] [Related]

  • 40. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Zipfel PF, Wiech T, Stea ED, Skerka C.
    J Am Soc Nephrol; 2020 Feb 20; 31(2):241-256. PubMed ID: 31980588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.